Barclays analyst Michael Leithead maintains Element Solutions (NYSE:ESI) with a Overweight and raises the price target from $21 to $24.
Why Are TScan Therapeutics Shares Are Shooting Higher Today
Amgen Inc (NASDAQ: AMGN) and TScan Therapeutics Inc (NASDAQ: TCRX) announced a multi-year collaboration to use TScan's proprietary target discovery platform, TargetScan, to identify the antigens recog